Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
EMA’s mCombriax Vaccine Recommendation
By
HEOR Staff Writer
March 3, 2026
EMA's mCombriax Vaccine Recommendation Ushers in Dual Protection Era The mCombriax vaccine recommendation from the European Medicines Agency (EMA) marks a milestone...
Childhood Immunization Reforms: Aligning U.S. Schedules with Global Standards
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
Balancing Pandemic Preparedness Priorities and Military Spending
HPV vaccination South Africa: Cervical Cancer Prevention
Strengthening Immunisation in the Eastern Mediterranean: WHO Launches Regiona...
Mental Healthcare for Youth: Addressing Substance Use and Chronic Conditions
The Impact of Immunosenescence on Ageing
Modifiable Risk Factors for Dementia: Insights from a 15-Year Study
Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndro...
Prevention is Better Than Cure: The Costs of the Pandemic Accord
An Era of Equitable Access: The Potential of the Pandemic Accord
How User-Centered Perspectives Foster Innovation in Digital Health Surveillan...
1
2
3
Next »